Equine influenza infection, Equine Infectious Diseases, pp.141-151, 2013. ,
A systematic review of recent advances in equine influenza vaccination, vol.2, pp.797-831, 2014. ,
The circumstances surrounding the outbreak and spread of equine influenza in South Africa, Rev. Ser. Tech, vol.18, pp.179-185, 1999. ,
The use of a recombinant canarypox-based equine influenza vaccine during the 2007 australian outbreak: A systematic review and summary ,
Management and environmental factors involved in equine influenza outbreaks in ireland, Equine Vet. J, vol.43, pp.608-617, 2007. ,
Epidemiological and virological investigations of equine influenza outbreaks in ireland, Influenza Other Resp. Viruses, pp.61-72, 2010. ,
Evolution and divergence of h3n8 equine influenza viruses circulating in the united kingdom from, vol.6, 2013. ,
Equine influenza (Infection with Equine Influenza Virus): Chapter 2.5, vol.7, 2016. ,
Establishing an acceptability threshold for equine influenza vaccines, Dev. Biol. Stand, vol.79, pp.137-146, 1992. ,
Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines, Vet. Rec, vol.134, pp.158-162, 1994. ,
A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of national hunt horses-A randomised blind study, vol.29, pp.3917-3922, 2011. ,
Whole inactivated equine influenza vaccine: Efficacy against a representative clade 2 equine influenza virus, ifngamma synthesis and duration of humoral immunity, Vet. Microbiol, vol.162, pp.396-407, 2013. ,
Boosting in equine influenza vaccination schedules: Timing and time for a re-evaluation of requirements of national and international authorities, Vet. J, vol.174, pp.449-450, 2007. ,
Duration of equine influenza virus shedding and infectivity in immunised horses after experimental infection with eiv a/eq2/richmond/1/07, Vet. Microbiol, vol.166, pp.22-34, 2013. ,
Evolution of equine influenza virus in vaccinated horses, J. Virol, vol.87, pp.4768-4771, 2013. ,
, , 2007.
Is there a benefit from an early booster vaccination in the control of equine influenza?, Vet. J, vol.174, pp.592-598, 2007. ,
Equine influenza vaccine (inactivated) monograph 0249, European Pharmacopoeia, pp.968-970, 2013. ,
explanation and elaboration: Updated guidelines for reporting parallel group randomised trials, Br. Med. J, vol.340, 2010. ,
statement: Updated guidelines for reporting parallel group randomised trials, Br. Med. J, vol.340, 2010. ,
Protection, systemic ifn and antibody responses induced by an iscom-based vaccine against a recent equine influenza virus in its natural host, Vet. Res, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00902919
A simple method of estimating fifty percente endpoints, Am. J. Hyg, vol.27, pp.493-497, 1938. ,
Refinement of the equine influenza model in the natural host: A meta-analysis to determine the benefits of individual nebulisation for experimental infection and vaccine evaluation in the face of decreased strain pathogenicity, Vet. Microbiol, vol.211, pp.150-159, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02167928
, The World Organisation for Animal Health (OIE), 2018.
Iscom-based equine influenza vaccine: Duration of immunity and randomised clinical trials to assess an accelerated schedule of immunisation and efficacy, Trials Vaccinol, vol.4, pp.61-70, 2015. ,
Efficacy of a whole inactivated ei vaccine against a recent eiv outbreak isolate and comparative detection of virus shedding, Vet. Immunol. Immunopathol, vol.136, pp.272-283, 2010. ,
Statistical Power Analysis for the Behavorial Sciences ,
, , p.400, 1988.
Influenza neuraminidase as a vaccine antigen, Curr. Top. Microbiol. Immunol, vol.333, pp.227-241, 2009. ,
Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase, J. Infect. Dis, vol.207, pp.974-981, 2013. ,
, OIE Equine influenza vaccine composition, vol.2, pp.86-87, 2017.
Report of the international equine influenza roundtable expert meeting at le touquet, normandy, Equine Vet. J, vol.46, pp.645-650, 2013. ,
The first safe inactivated equine influenza vaccine formulation adjuvanted with iscom-matrix that closes the immunity gap, vol.27, pp.5530-5537, 2009. ,
Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (alvac) vaccination, Vet. Immunol. Immunopathol, vol.135, pp.100-107, 2010. ,
Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza h3n8 virus in the protection of ponies from viral challenge, Am. J. Vet. Res, vol.68, pp.213-219, 2007. ,
How to meet the last oie expert surveillance panel recommendations on equine influenza (ei) vaccine composition: A review of the process required for the recombinant canarypox-based ei vaccine ,
Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with iscom-matrix, Vaccine, vol.28, pp.6989-6996, 2010. ,
,
, , vol.112, pp.307-314, 1970.
Duration of tetanus immunoglobulin g titres following basic immunisation of horses, Equine Vet. J, vol.48, pp.710-713, 2016. ,
Equine vaccines: How, when and why? Report of the vaccinology session ,
URL : https://hal.archives-ouvertes.fr/hal-02167907
Accelerated vaccination schedule provides protective levels of antibody and complete herd immunity to equine influenza, Equine Vet. J, vol.45, pp.235-239, 2013. ,
Comparison of primary vaccination regimes for equine influenza: Working towards an evidence-based regime, Equine Vet. J, vol.46, pp.669-673, 2014. ,
Equine influenza vaccine containing older h3n8 strains offers protection against a/eq/south africa/4/03 (h3n8) strain in a short-term vaccine efficacy study, Equine Vet. J, vol.39, pp.446-450, 2007. ,
Efficacy of a non-updated, matrix-c-based equine influenza subunit-tetanus vaccine following florida sublineage clade 2 challenge, Vet. Rec, vol.174, p.633, 2014. ,